SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Canuck Dave who wrote (35398)6/25/2003 4:55:51 PM
From: energyplay  Read Replies (2) of 74559
 
If Jim Grant turns bullish on US equities - run for the hills !

I have a small biotech called SciClone SCLN -

Today they reportedd pretty good results from the Phase III Japan trail of their main drug for Hepatitus B.

Moderate improvemnet with response & cure rates - but since Hep B is very tough, this is good news.

Main drug is Zandaxian, sort of an immune system helper - think hamburger helper for making white cells. Used in combination with other drugs.

Report hit at about 11 am Pacific time. Up 0.99 to 8.90.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext